EFFCT 发表于 2025-3-21 18:45:25

书目名称Resistance to Tyrosine Kinase Inhibitors影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0828464<br><br>        <br><br>书目名称Resistance to Tyrosine Kinase Inhibitors影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0828464<br><br>        <br><br>书目名称Resistance to Tyrosine Kinase Inhibitors网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0828464<br><br>        <br><br>书目名称Resistance to Tyrosine Kinase Inhibitors网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0828464<br><br>        <br><br>书目名称Resistance to Tyrosine Kinase Inhibitors被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0828464<br><br>        <br><br>书目名称Resistance to Tyrosine Kinase Inhibitors被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0828464<br><br>        <br><br>书目名称Resistance to Tyrosine Kinase Inhibitors年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0828464<br><br>        <br><br>书目名称Resistance to Tyrosine Kinase Inhibitors年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0828464<br><br>        <br><br>书目名称Resistance to Tyrosine Kinase Inhibitors读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0828464<br><br>        <br><br>书目名称Resistance to Tyrosine Kinase Inhibitors读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0828464<br><br>        <br><br>

allergen 发表于 2025-3-21 23:45:50

2196-5501 to common denominators of small-molecule and antibody-derive.The volume will serve as a primer on tyrosine kinase signaling and its importance in cancer. The volume will first introduce the common denominators of small-molecule and antibody-derived inhibitors, as well as the general phenomenon of re

事情 发表于 2025-3-22 03:36:01

Tyrosine Kinase Signaling Pathways in Normal and Cancer Cells,rcinogenesis. In this chapter, we will discuss signaling pathways engaging PTKs and their implications in the initiation and progression of several human malignancies. We will point out the principal cancer cell types known to be candidates for tyrosine kinases inhibitors (TKIs)-or monoclonal antibodies-based targeted therapies.

母猪 发表于 2025-3-22 06:21:19

http://reply.papertrans.cn/83/8285/828464/828464_4.png

colostrum 发表于 2025-3-22 10:09:48

http://reply.papertrans.cn/83/8285/828464/828464_5.png

易于交谈 发表于 2025-3-22 13:47:50

Resistance to Tyrosine Kinase Inhibitors in Different Types of Solid Cancer,ould facilitate the identification of actionable targets and development of new combination therapies for cancer patients. Although extensive studies have been applied to elucidate the underlying mechanisms, evidence is far from enough to establish a well-defined picture to correct resistance. The u

Initial 发表于 2025-3-22 18:00:03

http://reply.papertrans.cn/83/8285/828464/828464_7.png

Sad570 发表于 2025-3-22 23:16:38

http://reply.papertrans.cn/83/8285/828464/828464_8.png

BIBLE 发表于 2025-3-23 02:17:37

http://reply.papertrans.cn/83/8285/828464/828464_9.png

Hyperopia 发表于 2025-3-23 07:13:10

http://reply.papertrans.cn/83/8285/828464/828464_10.png
页: [1] 2 3 4
查看完整版本: Titlebook: Resistance to Tyrosine Kinase Inhibitors; Daniele Focosi Book 2016 Springer International Publishing Switzerland 2016 Cancer Cells.Inhibit